N

Neutrolis Inc

10 employees

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).

Basic info

Industry

biotechnology research

Sectors

Autoimmunity

Biotechnology

Immunology

Neutrophils

Medical

Inflammation

Life Science

Date founded

2017

Funding rounds raised

N

Neutrolis Inc raised undisclosed on October 1, 2019

Investors: Prefix Capital

FAQ